Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raffaele Addeo

Showing results (11-20 of 108) with videos related to

Pageof 11
Sort By:
Expert Opinion on Pharmacotherapy|April 9, 2009
Highlights of the Pananemia National Meeting of the Italian Southern Oncological Group (GOIM): pharmacological and molecular treatment of cancer-induced anemia. Sorrento, Italy, 19-20 December 2008Raffaele Addeo, Michele Caraglia, Salvatore Del Prete
Oncology Letters|June 25, 2014
Squamous cell carcinoma of the tongue in a female with advanced breast cancer: A case report of an elderly patient presenting with two types of cancerRaffaele Addeo, Alberto Napolitano, Liliana Montella, et al.
Expert Review of Hematology|September 13, 2014
Pharmacogenetics of methotrexate in pediatric hematological neoplasm treatment: does it need a personalized regimen based on MTHFR polymorphisms?Velia D'Angelo, Maria Ramaglia, Adriana Iannotta, et al.
Expert Opinion on Investigational Drugs|May 20, 2014
Erlotinib: early clinical development in brain cancerRaffaele Addeo, Silvia Zappavigna, Ciro Parlato, et al.
World Journal of Gastroenterology|July 29, 2016
Hepatocellular carcinoma: Will novel targeted drugs really impact the next future?Liliana Montella, Giovannella Palmieri, Raffaele Addeo, et al.
Expert Review of Anticancer Therapy|October 15, 2010
Latest developments in targeted therapy for hepatocellular carcinomaLiliana Montella, Raffaele Addeo, Michele Caraglia, et al.
Current Medical Research and Opinion|May 8, 2014
ASCO 2013: bevacizumab and glioblastoma--a marriage dissolution?Raffaele Addeo, Francesco Perri, Ciro Parlato, et al.
Expert Review of Hematology|November 19, 2010
Two faces for Janus: recombinant human erythropoiesis-stimulating agents and cancer mortalityRaffaele Addeo, Michele Caraglia, Nicola Frega, et al.
Expert Opinion on Investigational Drugs|July 10, 2025
Investigational new drugs to treat brain metastasis from non-small cell lung cancerPasquale Vitale, Giuseppe Lamberti, Ilaria di Giovanni, et al.
Expert Opinion on Biological Therapy|January 18, 2019
CheckMate 141 trial: all that glitters is not goldRaffaele Addeo, Massimo Ghiani, Francesco Merlino, et al.
Pageof 11

Showing results (11-20 of 108) with videos related to

Sort By:
Pageof 11
Expert Opinion on Pharmacotherapy|April 9, 2009
Highlights of the Pananemia National Meeting of the Italian Southern Oncological Group (GOIM): pharmacological and molecular treatment of cancer-induced anemia. Sorrento, Italy, 19-20 December 2008Raffaele Addeo, Michele Caraglia, Salvatore Del Prete
Oncology Letters|June 25, 2014
Squamous cell carcinoma of the tongue in a female with advanced breast cancer: A case report of an elderly patient presenting with two types of cancerRaffaele Addeo, Alberto Napolitano, Liliana Montella, et al.
Expert Review of Hematology|September 13, 2014
Pharmacogenetics of methotrexate in pediatric hematological neoplasm treatment: does it need a personalized regimen based on MTHFR polymorphisms?Velia D'Angelo, Maria Ramaglia, Adriana Iannotta, et al.
Expert Opinion on Investigational Drugs|May 20, 2014
Erlotinib: early clinical development in brain cancerRaffaele Addeo, Silvia Zappavigna, Ciro Parlato, et al.
World Journal of Gastroenterology|July 29, 2016
Hepatocellular carcinoma: Will novel targeted drugs really impact the next future?Liliana Montella, Giovannella Palmieri, Raffaele Addeo, et al.
Expert Review of Anticancer Therapy|October 15, 2010
Latest developments in targeted therapy for hepatocellular carcinomaLiliana Montella, Raffaele Addeo, Michele Caraglia, et al.
Current Medical Research and Opinion|May 8, 2014
ASCO 2013: bevacizumab and glioblastoma--a marriage dissolution?Raffaele Addeo, Francesco Perri, Ciro Parlato, et al.
Expert Review of Hematology|November 19, 2010
Two faces for Janus: recombinant human erythropoiesis-stimulating agents and cancer mortalityRaffaele Addeo, Michele Caraglia, Nicola Frega, et al.
Expert Opinion on Investigational Drugs|July 10, 2025
Investigational new drugs to treat brain metastasis from non-small cell lung cancerPasquale Vitale, Giuseppe Lamberti, Ilaria di Giovanni, et al.
Expert Opinion on Biological Therapy|January 18, 2019
CheckMate 141 trial: all that glitters is not goldRaffaele Addeo, Massimo Ghiani, Francesco Merlino, et al.
Pageof 11